Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Bone Cancer Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 769
Abbreviations 769
Definitions 769
Research Methodology 770
Secondary Research 770
About GlobalData 771
Contact Us 771
Disclaimer 771
Source 771

List of Tables
Bone Cancer Therapeutics, Global, Clinical Trials by Region, 2018* 7
Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Bone Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 18
Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Bone Cancer Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Bone Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Bone Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 15
Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 18
Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Bone Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 770

Companies Mentioned
- Novartis AG
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Amgen Inc
- Pfizer Inc
- Merck & Co Inc
- Takeda Pharmaceutical Co Ltd
- AstraZeneca Plc
- Eli Lilly and Co
- Bristol-Myers Squibb Co